European Archives - Page 870 of 1452 - European Medical Journal

Different Types of Paediatric Myelitis Can Be Distinguished by MRI Features

DISTINGUISHING between different conditions of the spine is important in order to provide patients with the correct diagnosis and treatment…

Could MR-Guided Ultrasound Improve Drug Delivery to Treat Brain Metastases?

MR-guided focused ultrasound improved delivery of trastuzumab to the brain. Consequently, the drug was able to reduce the size of the tumour…

Treatment Tapering and Withdrawal in People with Rheumatoid Arthritis in Stable Remission

The Rheumatoid Arthritis in Ongoing Remission (RETRO) study aimed to determine outcomes following tapering and withdrawal…

COVID-19 Vaccination in People with Multiple Sclerosis

Consequently, for interferon-β, teriflunomide, and dimethyl fumarate, COVID-19 vaccination is “likely to be effective…”

Webinar: Solving the Puzzle of Recurrent Abdominal Pain

Professors Tacke and Cassiman will share their clinical experience of a disease often misdiagnosed or with delayed diagnosis.

Harnessing Healthcare’s Future

Michael Blackhurst, Founding Director, JTJ Services explores the value of self-reflection, the rise of NFTs in healthcare and much more.

Harvesting the Fruits of Pulmonary Disease Research: Learnings from the COVID-19 Pandemic

Prof. Felix Herth and Prof. Dave Singh discuss current and future plans of the EARCO research collaboration.

'Diagnosis, Treatment, Impact, and Unmet Needs of People with Mycosis Fungoides and Sézary Syndrome'?

Richard Cowan, oncologist and expert on cutaneous T-cell lymphomas, provides insights into both mycosis fungoides and sézary syndrome.

Dr Emma Roffe and Eric Low on combination treatments

Dr Emma Roffe, Takeda UK, and Eric Low, Myeloma UK, talk about the challenge of combination treatments.

Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesaemia: Is There a Best Replacement Strategy?

Over the past few decades, there have been important advances in cancer therapeutics, including a shift from traditional cytotoxic…